For instance, brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) have been proven to benefit the survival and development of dopaminergic neurons and thus may bolster PD treatments through the nigrostriatal pathway. Here, BDNF is linked to Parkinson disease.